Arak, Hacı, and Tülay Kuş. “Prognostic and Predictive Significance of HER2-Low Expression in Metastatic Hormone Receptor Positive Breast Cancer Patients Receiving CDK4-6 Inhibitor Therapy”. European Journal of Therapeutics (May 23, 2024). Accessed June 30, 2024. https://eurjther.com/index.php/home/article/view/2151.